Long-Read vs. Short-Read Sequencing: What’s the Difference?

When searching for the genetic cause of a rare disease, the type of sequencing technology used can make all the difference. The two primary methods used today are short-read sequencing and long-read sequencing. While both aim to read a person’s DNA, they do so on a vastly different scale.
Think of the genome as a massive book. Short-read sequencing is like reading the book by looking at millions of individual words, then trying to piece the story together. It’s very accurate for spelling each word, but it can struggle when sentences are repetitive or the structure is complex. Long-read sequencing, in contrast, reads entire paragraphs or pages at a time, making it much easier to understand the overall story and spot sections where large chunks of text have been moved, deleted, or repeated.
Frequently asked questions
What is the main advantage of long-read sequencing?
Its main advantage is the ability to span complex genomic regions, like repetitive DNA and large structural variants. This provides a more complete and accurate picture of the genome, revealing genetic changes that other methods can miss.
Is short-read sequencing still useful?
Yes, absolutely. Short-read sequencing is highly accurate for detecting small variants, such as single nucleotide changes (SNPs), and remains a cost-effective and powerful tool for many standard genetic tests, including exome sequencing.
Which is more expensive, long-read or short-read?
Historically, long-read sequencing has been more expensive per base of DNA read. However, costs are falling rapidly as the technology matures, making it increasingly accessible for complex clinical cases and research.
Can long-read sequencing find answers when other tests fail?
Yes, for certain patients. In cases where exome or genome sequencing with short-reads did not yield a diagnosis, long-read sequencing can increase the diagnostic yield by identifying large, complex variants as the cause of a rare disease.
Understanding the Basics of DNA Sequencing
The human genome contains about 3 billion letters of DNA. It’s impossible to read this entire sequence from end to end in one go. All sequencing technologies work on a fundamental principle: break the DNA into smaller, manageable pieces, read these pieces, and then use computers to assemble them back into the correct order.
The critical difference between sequencing methods comes down to the length of those initial pieces. This is what we call read length, and it dramatically impacts what we can learn from the data.
A Closer Look at Short-Read Sequencing
Short-read sequencing has been the dominant technology for over a decade and has powered countless discoveries. It generates reads that are typically between 50 and 300 base pairs long.

The Technology and Its Strengths
The most common form of short-read sequencing works by attaching DNA fragments to a surface and reading them one base at a time in a massively parallel process. This method, known as sequencing-by-synthesis, has several key strengths:
- High Accuracy: The error rate for each individual base is extremely low, making it excellent for detecting single-letter changes (SNPs) and small insertions or deletions.
- Cost-Effective: Its efficiency has driven down the cost of sequencing, making whole exome and whole genome sequencing widely accessible.
- High Throughput: It can generate enormous amounts of data in a single run, allowing many samples to be processed at once.
Limitations of the Short-Read Approach
The main challenge for short-read sequencing lies in the assembly process. The human genome is full of repetitive sections and highly complex regions. When you only have short reads, piecing these areas together correctly is like trying to solve a jigsaw puzzle where many pieces are identical shades of blue sky. This can lead to gaps or errors in the assembled genome, causing certain types of genetic variants to be missed entirely.
The Power of Long-Read Sequencing
Long-read sequencing, a newer technology, addresses the primary limitation of the short-read approach. It can generate reads that are thousands, or even tens of thousands, of base pairs long.

Seeing the Complete Genomic Picture
By reading much longer stretches of DNA, long-read technologies provide the context needed to navigate the genome’s most difficult regions. If short-reads are words, long-reads are full paragraphs. This capability makes it much easier to assemble a complete and accurate genome.
Solving Diagnostic Challenges in Rare Disease
For rare disease diagnostics, the ability to see the bigger picture is transformative. Long-read sequencing excels at detecting large-scale genetic changes that are a known cause of many rare conditions but are difficult to find with short reads. These include:
- Structural Variants (SVs): These are large rearrangements of DNA, such as deletions, duplications, inversions, or translocations of entire gene segments. Research shows that long-read sequencing significantly improves SV detection over short-read methods.
- Repeat Expansion Disorders: Some diseases, like Huntington’s disease and Fragile X syndrome, are caused by the abnormal expansion of a short, repetitive DNA sequence. Accurately measuring the length of these repeats is challenging for short reads but is a strength of long-read technology, as detailed in OMIM entries for such conditions.
- Gene Fusions and Complex Rearrangements: In some cases, parts of two different genes can be fused together. Long reads can span the entire fusion event, providing a clear picture of what has happened.
When to Choose Long-Read Sequencing
While short-read sequencing remains the workhorse for many genetic tests, long-read sequencing is becoming the go-to tool for solving the most challenging cases. A clinician might consider it when:
- A patient has undergone whole exome or whole genome sequencing with short-reads, but no diagnosis was found.
- A specific condition caused by a repeat expansion or complex structural variant is suspected.
- A more complete, high-quality reference genome is needed for research or complex analysis.
If standard genetic testing has not provided a clear answer, the complex variants that long-read sequencing can uncover might hold the key. Understanding which technology is right for a specific medical situation is a crucial step toward a diagnosis.
Considering long-read sequencing? Let 3billion take it from here. We manage the entire process — from sequencing (performed by an external sequencing partner) through analysis to final report delivery. Questions about the process, pricing, or anything else? Tap the button below to reach out today.
Get exclusive rare disease updates
from 3billion.

Soo-jung Baek
As a marketer, I strive to empower the rare disease community by sharing meaningful insights backed by our company’s expertise.





